期刊文献+

不同剂量链脲佐菌素建立妊娠糖尿病小鼠模型稳定性比较 被引量:2

Comparison on the stability of the mouse model of gestational diabetes established by different doses of streptozotocin
下载PDF
导出
摘要 目的探讨链脲佐菌素方法建立妊娠糖尿病小鼠模型中不同给药剂量对成模率及稳定性的影响。方法将40只C57BL/6J孕鼠随机分为对照组(10只)和实验组(链脲佐菌素低、中、高剂量组,每组10只),对照组一次性腹腔注射等剂量的柠檬酸缓冲液,实验组分别予一次性腹腔注射现配链脲佐菌素溶液20 mg/kg、50 mg/kg、100 mg/kg,之后均给予普通饲料喂养,自由进水。分别于妊娠第3、10、18天测空腹血糖与体质量,并观察饮水量与尿量变化,比较孕鼠成模情况。结果 20 mg/kg STZ注射组成模率为40%,50 mg/kg链脲佐菌素组成模率为70%,100 mg/kg STZ注射组成模率为50%。空腹血糖与对照组相比较其高血糖状态持续时间长,且体质量明显下降,差异具有统计学意义(P<0.05)。结论链脲佐菌素50 mg/kg腹腔注射C57BL/6J孕鼠是建立妊娠糖尿病小鼠模型的最佳剂量,具有较好的稳定性。 Objective To investigate the effect of different doses of streptozotocin (STZ) on the stability of the mouse model of gestational diabetes established by streptozotocin. Methods Forty C57BL/6J pregnant mice were randomly divided into the control group (10 mice) and the streptozotocin group (20 mg/kg STZ group, 50 mg/kg STZ group and 100 mg/kg STZ group, each with l0 mice). The mice were injected intraperitoneally with equal dose of ci^ate buffer, STZ solution 20 mg/kg, 50 mg/kg, 100 mg/kg, respectively, according to their assigned groups, and then they were given normal feeding. The fasting blood glucose and body mass were measured on the third, 10th, 18th day of pregnancy, and the water intake and urine output changes were also observed. Finally the modeling rates of the pregnant mice were compared between the different groups. Results The modeling rate was found to be 40% for 20 mg/kg STZ group, 70% for 50 mg/kg STZ group, 50% for 100 mg/kg STZ group. Compared with the control group, the levels of fasting blood glucose was significantly higher in 50 mg/kg STZ group, and the body weight was signifi- cantly lower (P〈O.05). The state of hyperglycemia retained continually and steadily. Conclusion 50 mg/kg is the op- timal dose for intraperitoneal injection of streptozotocin into C57BL/6J pregnant mice to establish gestational diabetes mouse model, with good stability.
出处 《海南医学》 CAS 2013年第23期3436-3438,共3页 Hainan Medical Journal
基金 宁夏自然科学基金(编号:NZ1214 NZ07101) 宁夏科技公关项目(编号:2009年)
关键词 链脲佐菌素 妊娠糖尿病 小鼠 模型 Streptozotocin Gestational diabetes Mice Model
  • 相关文献

参考文献10

  • 1American Diabetes Association. Diagnosis and classification of diabetes mellitus[J].{H}DIABETES CARE,201 ,(09):107-109.
  • 2Carr DB,Utzschneider KM,Hull RL. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes[J].{H}DIABETES CARE,2006,(09):125-129.
  • 3Panchal SK,Brown L. Rodent models for metabolic syndrome research journal of biomedicine and biotechnology[J].{H}DIABETES CARE,2010,(10):1-14.
  • 4李聪然,游雪甫,蒋建东.糖尿病动物模型及研究进展[J].中国比较医学杂志,2005,15(1):59-63. 被引量:93
  • 5Lenzen S. The mechanisms of alloxan and streptozotocin induced diabetes[J].{H}DIABETOLOGIA,2007,(10):216-226.
  • 6Szkudelshi T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas[J].{H}Physiological Research,2001,(05):536-546.
  • 7张芳林,李果,刘优萍,丁伟,殷峻,许光武,张迪,周文中,罗敏.2型糖尿病大鼠模型的建立及其糖代谢特征分析[J].中国实验动物学报,2002,10(1):16-20. 被引量:132
  • 8刘霆,张桂珍,卜丽莎,牟明威.STZ小剂量多次注射诱导大鼠胰岛素依赖性糖尿病动物模型探讨[J].白求恩医科大学学报,2001,27(6):578-580. 被引量:22
  • 9Iessi IL,Bueno A,Sinzato YK. Evaluation of neonatally induced mild diabetesin rats Maternal and fetal repercussions[J].Diabetol Metab Syndr,2010,(01):37.
  • 10Kiss AC,Lima PH,Sinzato YK. Animal models for clinical and gestational diabetes:maternal and fetal outcomes[J].Diabetol Metab Syndr,2009.21.

二级参考文献39

  • 1蒋虹,王艳蓉,张永蓉,汪歌.NOD小鼠糖尿病病症的初步观察[J].中国实验动物学杂志,1998,8(3):157-159. 被引量:3
  • 2杜冠华 李学军 张永祥 等译.药理学实验指南-新药发现和药理学评价[T].北京:科学出版社,2001.698-712.
  • 3Rossini AA, Williams RM, Appel MC, et al. Sex difference in the multiple-dose streptozotocin model of diabetes [J]. Endocrinology,1978,103: 1518 - 1520.
  • 4Anastasi E, Dotta F, Tiberti C, et al. Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose Stz mouse model of diabetes [ J ]. Autoimmunity, 1999, 29:249 -256.
  • 5Bach JF. Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases[ J]. Arthritis Res, 2002, Suppl 3: S1 - S15.
  • 6Shimada A, Charlton B, Taylor-Edwards C, et al. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetes mice[J]. Diabetes, 1996, 45(8): 1063 - 1067.
  • 7Baeder WL, Sredy J, Sehgal SN, et al. Rapamycin prevents the onset of insulin dependent diabetes mellitus (IDDM) in NOD mice[J].Clin Exp Immunol, 1992,89:174 - 178.
  • 8Nicoletti F, Di Marco R, Barcellini W, et al. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor [J]. Eur J Immunol, 1994, 24:1843 -1847.
  • 9Hunger RE, Carnaud C, Garcia 1, et al. Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55 [J]. Eur J Immunol, 1997,27 (1):255 - 261.
  • 10Orban T, Landaker E, Ruan Z, et al. High-fructose diet preserves β-cell mass and prevents diabetes in nonobese diabetic mice: A potential role for increased insulin receptor substrate-2 expression [J]. Metabolism,2001,50(11): 1369 - 1376.

共引文献239

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部